JAK2 and cancer: Knock-in of a non-phosphorylatable CARM1 mutation also downregulated the expression of BMI-1, which is a regulator of self-renewal that plays a role in JAK2-V617F mutant hematopoietic stem cells64, as well as other cancer stem cell phenotypes.